BIO
Bio-Rad Laboratories, Inc.
NYSE · Healthcare · Medical - Devices · US
$386.11
−0.46%Margins
Gross margin
51.9%
EBITDA margin
20.6%
EBIT margin
9.1%
Net margin
8.6%
FCF margin
13.6%
3.1%
Return on equity
2.2%
Return on assets
2.8%
Return on invested capital
0.26x
Asset turnover
$492.6M
Cash from operations
$61
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026